Source: Blair, J. D., et al. Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation. J. Vis. Exp. (2016).
This video demonstrates a technique of zinc-finger nuclease-based genome editing in human pluripotent stem cells (hPSCs). As hPSCs can potentially be differentiated into various cell types, this technology is helpful for in vitro pathological and pharmacological studies in a patient-specific manner.
All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board.
1. Prepare Stem Cells for Editing
2. Editing Pluripotent Stem Cells
3. Selection of Positive Colonies
Figure 1. Schematic of gene edited AAVS1 locus using the AAV-CAGGS-EGFP repair template. Modified from Hockemeyer et al., 2009.
The authors have nothing to disclose.
DMEM/F12 | Life Technologies | 11320082 | |
Fetal Bovine Serum (HI) | Life Technologies | 10082-147 | |
Knockout Serum | Life Technologies | 10828-028 | |
Fibroblast Growth Factor – basic | Life Technologies | PHG0261 | |
Pen/Strep | Life Technologies | 15140-122 | |
Glutamine | Life Technologies | 25030-081 | |
MEM NEAA | Life Technologies | 11140-050 | |
2-mercaptoethanol | Life Technologies | 21985-023 | |
Y-27632 | Calbiochem | 688000 | |
6-well plates | Corning | 3506 | |
4 mm Electroporation cuvettes | Bio-rad | 165-2081 | |
X-cel gene pulser II | Bio-rad | 165-2661 | |
0.25% Trypsin-EDTA | Life Technologies | 25200-056 | |
10× Phosphate buffered saline (PBS) pH7.4 | Life Technologies | 70011-044 | |
Puromycin | Life Technologies | A11138-02 |